fullerene c60 has been researched along with gallic acid in 6 studies
Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (gallic acid) | Trials (gallic acid) | Recent Studies (post-2010) (gallic acid) |
---|---|---|---|---|---|
3,806 | 5 | 2,170 | 4,793 | 42 | 2,579 |
Protein | Taxonomy | fullerene c60 (IC50) | gallic acid (IC50) |
---|---|---|---|
Urokinase-type plasminogen activator | Homo sapiens (human) | 6.6 | |
Tissue-type plasminogen activator | Homo sapiens (human) | 6.6 | |
Plasminogen activator inhibitor 1 | Homo sapiens (human) | 6.6 | |
Urokinase-type plasminogen activator | Mus musculus (house mouse) | 6.6 | |
72 kDa type IV collagenase | Homo sapiens (human) | 4.03 | |
Matrilysin | Homo sapiens (human) | 4.03 | |
Dipeptidyl peptidase 4 | Homo sapiens (human) | 4.65 | |
Alpha-synuclein | Homo sapiens (human) | 4.43 | |
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | Homo sapiens (human) | 4.03 | |
Polypeptide N-acetylgalactosaminyltransferase 2 | Homo sapiens (human) | 1.37 | |
Alpha-(1,3)-fucosyltransferase 7 | Homo sapiens (human) | 4.03 | |
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | Homo sapiens (human) | 4.03 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allegood, M; Ke, PC; Lin, S; Rao, AM; Reid, ML; Salonen, E; Vattulainen, I; Wang, X | 1 |
Chen, J; Peijnenburg, WJ; Sun, Q; Wang, Z | 1 |
Ke, PC; Klaine, SJ; Mount, AS; Seda, BC | 1 |
Barnoud, J; Monticelli, L; Orlowski, A; Vattulainen, I | 1 |
Antonelli, ML; Cannistraro, S; Coppari, E; Favero, G; Lanzellotto, C; Mazzei, F; Tortolini, C | 1 |
Antiochia, R; Favero, G; Mazzei, F; Sanzò, G; Tortolini, C | 1 |
6 other study(ies) available for fullerene c60 and gallic acid
Article | Year |
---|---|
Real-time translocation of fullerene reveals cell contraction.
Topics: Cell Membrane; Computer Simulation; Fullerenes; Gallic Acid; HT29 Cells; Humans; Models, Molecular; Nanoparticles; Nuclear Envelope; Phenol | 2008 |
C60-DOM interactions and effects on C60 apparent solubility: a molecular mechanics and density functional theory study.
Topics: Adsorption; Carbon; Fullerenes; Gallic Acid; Humic Substances; Kinetics; Models, Molecular; Solubility; Water; Water Pollutants, Chemical | 2011 |
Toxicity of aqueous C70-gallic acid suspension in Daphnia magna.
Topics: Animals; Daphnia; Fullerenes; Gallic Acid; Glutathione Peroxidase; Lipid Peroxidation; Oxidation-Reduction; Oxidative Stress; Superoxide Dismutase; Water Pollutants, Chemical | 2012 |
Interaction of C70 fullerene with the Kv1.2 potassium channel.
Topics: Fullerenes; Gallic Acid; Kv1.2 Potassium Channel; Models, Molecular; Molecular Dynamics Simulation | 2012 |
Nanostructured enzymatic biosensor based on fullerene and gold nanoparticles: preparation, characterization and analytical applications.
Topics: Biosensing Techniques; Conductometry; Equipment Design; Equipment Failure Analysis; Food Analysis; Fullerenes; Gallic Acid; Gold; Laccase; Metal Nanoparticles; Microelectrodes; Nanotechnology; Reproducibility of Results; Sensitivity and Specificity; Wine | 2014 |
Application of a Nanostructured Enzymatic Biosensor Based on Fullerene and Gold Nanoparticles to Polyphenol Detection.
Topics: Biosensing Techniques; Calibration; Electrochemical Techniques; Electrodes; Enzymes; Equipment Design; Fullerenes; Gallic Acid; Gold; Laccase; Metal Nanoparticles; Polyphenols; Wine | 2017 |